Sleep News and Research

Latest Sleep News and Research

Astellas Pharma and XenoPort submit NDA in Japan for PMDA approval

Astellas Pharma Inc. and XenoPort, Inc. today announced that a new drug application (NDA) has been filed with the Pharmaceuticals and Medical Device Agency (PMDA) in Japan for ASP8825 (gabapentin enacarbil), also known as XP13512, as a potential treatment for restless legs syndrome (RLS).

19 Nov 2009

System to help identify patients at high risk of developing delirium

A specialist in caring for elderly patients, Turner-Hubbard is a geriatric nurse practitioner trained to quickly spot the sudden changes in mental status that signal the onset of the sudden, severe confusion known as delirium. She knows the hospital “triggers” that can bring on fluctuations in behavior: blood loss during surgery, anesthesia, pain medications and anti-anxiety drugs, infections, dehydration, IV lines and catheters, as well as being immobilized for an extended period of time.

19 Nov 2009

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Pfizer Inc announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for the prevention of invasive pneumococcal disease in infants and young children.

19 Nov 2009

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

Every two years, 2,000 senior Group Health patients check in with the Adult Changes in Thought (ACT) study. The joint project between Group Health Research Institute and the University of Washington (UW) focuses on finding ways to delay or prevent dementia, including Alzheimer's disease, and declines in memory and thinking.

19 Nov 2009

Baby's sleep position can predict misshapen skull condition

A baby's sleep position is the best predictor of a misshapen skull condition known as deformational plagiocephaly - or the development of flat spots on an infant's head - according to findings reported by Arizona State University scientists in the December issue of the journal Pediatrics.

18 Nov 2009

Combination of night work, overtime and shortened sleep can increase risk of stroke and heart disease

A new study published in the current issue of Archives of Environmental & Occupational Health (vol. 64, No. 3) shows that this combination of night work, overtime and shortened sleep can contribute to the development among police officers of the metabolic syndrome, a combination of unhealthful factors that increase the risk of cardiovascular disease (CVD), primarily heart disease and stroke.

18 Nov 2009

CMS policy changes to drive the sleep management devices market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, policy changes made by the Center for Medicare and Medicaid Services (CMS) will cause a surge in obstructive sleep apnea (OSA) diagnostic testing and treatment. MRG's new US Market Opportunities for Respiratory and Sleep Management Devices 2010 report finds that increasing reimbursement opportunities for OSA diagnosis and treatment will drive the OSA market to $1.5 billion by 2014.

17 Nov 2009

Lack of sleep can lead to devastating errors, says new study

Sleep deprivation adversely affects automatic, accurate responses and can lead to potentially devastating errors, a finding of particular concern among firefighters, police officers, soldiers and others who work in a sleep-deprived state, University of Texas at Austin researchers say.

17 Nov 2009

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need.

17 Nov 2009

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

NeurogesX, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Qutenza(TM) (capsaicin) 8% patch, the first and only product containing prescription strength capsaicin, for the management of neuropathic pain due to postherpetic neuralgia (PHN), the nerve pain which can follow shingles.

17 Nov 2009

Health Mason software to streamline health care claim payment process

With health care reform taking the national spotlight, the sole point of agreement by all parties is that some form of change is necessary. Many health care industry experts believe that now is the worst time for government-mandated change because innovation has already begun to occur organically from within the industry. One Franklin Tennessee-based software company is defining that innovation and garnering attention in the industry.

17 Nov 2009

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

NovaDel Pharma Inc. today announced its entry into an exclusive license and distribution agreement with ECR Pharmaceuticals Company, Inc., a wholly owned subsidiary of Hi-Tech Pharmacal Co., Inc. to commercialize and manufacture ZolpiMist™ in the United States and Canada. ZolpiMist™ is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

16 Nov 2009

Cortex Pharmaceuticals reports a net loss of $0.06 per share for the quarter ended September 30, 2009

Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of $3,243,000, or $0.06 per share for the quarter ended September 30, 2009 compared with a net loss applicable to common stock of $3,148,000, or $0.07 per share for the corresponding prior year period.

16 Nov 2009

Positive results from Winston Laboratories' Civamide Patch trial

Winston Laboratories, Inc., a wholly-owned subsidiary of Winston Pharmaceuticals, Inc. today announced positive top-line results from Study WL1001-04-03, a Phase II clinical trial evaluating the safety and efficacy of the company's patch formulation of Civamide, a novel TRPV-1 receptor modulator in the treatment of post-herpetic neuralgia (PHN).

16 Nov 2009

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Fewer than one-third of patients with heart failure are taking the three types of medications that are most effective in prolonging life and improving quality of life. The November issue of Mayo Clinic Health Letter provides an overview of treatments recommended by national guidelines.

16 Nov 2009

Self-care tips for hemorrhoids from Mayo Clinic

By about age 50, more than half of adults have dealt with hemorrhoids. The November issue of Mayo Clinic Health Letter covers home treatments that can relieve symptoms of this common and embarrassing problem.

16 Nov 2009

Orthopedic surgeon specializes in cutting-edge shoulder procedures from a 45-minute technique

Orthopedic surgeon, Dr. Corey G. Solman specializes in cutting-edge shoulder procedures including everything from a 45-minute technique called shoulder resurfacing to a reversed shoulder replacement that relieves pain, restores shoulder function and improves range of motion.

13 Nov 2009

Medtronic launches an educational campaign to raise awareness of overactive bladder

Medtronic, Inc. today announced the kick-off of an educational campaign aimed at raising awareness among women of overactive bladder (OAB), a serious condition that can severely impact patients’ lives. This new campaign, conducted in partnership with leading patient advocacy groups focused on women’s health will help to raise awareness of the prevalence of bladder control problems and encourage patients to find effective treatment options – including and beyond medications.

13 Nov 2009

Transcept Pharmaceuticals reports financial results for the third quarter of 2009

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.

13 Nov 2009

D-Link to showcase its Green networking hardware at the HealthAchieve2009 conference

D-Link has been selected to showcase its environmentally responsible Green networking hardware as part of the Venture Green program in this year's HealthAchieve2009 conference and exhibition on Nov. 16-17 at the Metro Toronto Convention Centre.

12 Nov 2009

Sleep News and Research

Latest Sleep News and Research

Astellas Pharma and XenoPort submit NDA in Japan for PMDA approval

System to help identify patients at high risk of developing delirium

FDA Advisory Committee votes in support of Pfizer's Prevnar 13

Joint project focuses on finding ways to prevent dementia, including Alzheimer's disease

Baby's sleep position can predict misshapen skull condition

Combination of night work, overtime and shortened sleep can increase risk of stroke and heart disease

CMS policy changes to drive the sleep management devices market

Lack of sleep can lead to devastating errors, says new study

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

Health Mason software to streamline health care claim payment process

ECR Pharmaceuticals to commercialize and manufacture ZolpiMist in the U.S. and Canada

Cortex Pharmaceuticals reports a net loss of $0.06 per share for the quarter ended September 30, 2009

Positive results from Winston Laboratories' Civamide Patch trial

Mayo Clinic Health Letter provides treatment options for people with heart disorders

Self-care tips for hemorrhoids from Mayo Clinic

Orthopedic surgeon specializes in cutting-edge shoulder procedures from a 45-minute technique

Medtronic launches an educational campaign to raise awareness of overactive bladder

Transcept Pharmaceuticals reports financial results for the third quarter of 2009

D-Link to showcase its Green networking hardware at the HealthAchieve2009 conference

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Sleep News and Research

Latest Sleep News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in